P0201 Circulating biomarkers and outcomes in a phase 2 trial of first-line everolimus alternating with sunitinib for advanced renal cell carcinoma (ANZUP 0901—the EVERSUN Trial)

2014 ◽  
Vol 50 ◽  
pp. e65
Author(s):  
S. Yip ◽  
N. Pavlakis ◽  
R. Harvie ◽  
A. Martin ◽  
A. Hudson ◽  
...  
2015 ◽  
Vol 26 (6) ◽  
pp. 1118-1123 ◽  
Author(s):  
I.D. Davis ◽  
A. Long ◽  
S. Yip ◽  
D. Espinoza ◽  
J.F. Thompson ◽  
...  

2013 ◽  
Vol 14 (12) ◽  
pp. 1233-1242 ◽  
Author(s):  
Brian I Rini ◽  
Bohuslav Melichar ◽  
Takeshi Ueda ◽  
Viktor Grünwald ◽  
Mayer N Fishman ◽  
...  

Cancer ◽  
2009 ◽  
pp. NA-NA ◽  
Author(s):  
Eric Jonasch ◽  
Paul Corn ◽  
Lance C. Pagliaro ◽  
Carla L. Warneke ◽  
Marcella M. Johnson ◽  
...  

2015 ◽  
Vol 13 (6) ◽  
pp. 531-539.e1 ◽  
Author(s):  
Michael A. Carducci ◽  
Judith Manola ◽  
Suresh G. Nair ◽  
Glenn Liu ◽  
Steven Rousey ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document